Interaction of mitochondrial fusion and transmembrane potential in diabetic cardiovascular damage
Interaction of mitochondrial fusion and transmembrane potential in diabetic cardiovascular damage
批准号:
8997287
负责人:
ROBERT W GILKERSON
金额:
$10.9万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-01 至 2020-02-29
关键词:
AddressApoptosisBioenergeticsBiological AssayBiomedical ResearchCardiacCardiovascular DiseasesCardiovascular systemCause of DeathCell SurvivalCellsCleaved cellClinicalComplicationDataDevelopmentDiabetes MellitusDynaminElectron TransportEquilibriumEventFUS-1 ProteinFunctional ImagingGoalsHandHeartHeart failureHispanic-serving InstitutionHomeostasisHumanImageIn VitroIndividualInflammationInflammatoryInner mitochondrial membraneInterleukin-6KnowledgeLeftLinkMediatingMembrane PotentialsMethodsMitochondriaNeuromuscular DiseasesNon-Insulin-Dependent Diabetes MellitusOptic AtrophyOrganellesOxidantsPathogenesisPathologyPeptide HydrolasesPopulationPrevalencePreventivePropertyProtein IsoformsProteinsPublic HealthPublicationsResearchResearch PersonnelStressStructureStructure-Activity RelationshipStudentsSystemTNF geneUnderrepresented StudentsUnited States National Institutes of Healthbasebiological adaptation to stresscareercohortcytokinediabeticin vivomitochondrial dysfunctionmortalitynovelnovel therapeuticsosteosarcomaprogramspublic health relevanceresearch studyresponsetranslational approachtranslational study
中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal explores the interaction of mitochondrial fusion dynamics and transmembrane potential (∆ψm) as an underlying mechanism and translational target in diabetic cardiovascular damage. Type 2 diabetes mellitus is a rapidly-increasing public health concern, causing decreased cardiac efficiency as the leading cause of mortality among Type 2 diabetics. A range of clinical and experimental data suggests that the cytokine-mediated inflammation that drives diabetic pathology directly damages mitochondria, the organellar network responsible for cellular bioenergetics. Crucially, however, it is unknown what level of mitochondrial damage can be sustained in highly-oxidative cardiac cells before pathology ensues. Our previous studies of mitochondrial structure/function in neuromuscular disease, utilizing cell-based imaging and functional assays, provide a ready approach to address this gap in knowledge. To maintain bioenergetic homeostasis, mitochondria balance their organization between a united, reticular network (OPA1-mediated fusion) and a fragmented population of individual organelles (DRP1-mediated fission). The ∆ψm across the mitochondrial inner membrane is required for mitochondrial fusion, linking organellar function and structural dynamics. Strikingly, our preliminary data indicate that a sharply-defined threshold of 50% of ∆ψm is required for mitochondrial fusion. This threshold is independent of mitochondrial fission activity, and appears to be mediated by OMA1, a stress-response protease that has been shown to cleave the mitochondrial OPA1 fusion protein in response to low ∆ψm. Accordingly, we hypothesize that this threshold is an intrinsic property of human mitochondria mediated by expression of OPA1, and is damaged by cytokines, committing cardiac cells to apoptosis. The proposed aims mechanistically explore this threshold and the impacts of cytokine-mediated damage on ∆ψm and fusion dynamics, with major potential for a novel translational approach protecting cardiac mitochondria against cytokine-mediated damage. These aims an excellent fit with the outlined priorites for the SCORE SC3 mechanism, as the proposal will extend knowledge of mitochondrial homeostasis into the context of a leading public health problem, and will build biomedical research and enhance student research access at a leading Hispanic-serving institution that has not been a major recipient of NIH support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interaction of mitochondrial fusion and transmembrane potential in diabetic cardiovascular damage
-
批准号:9234561
-
项目类别:
-
资助金额:$10.9万
-
财政年份:2016
-
负责人:ROBERT W GILKERSON
-
依托单位:
Interaction of mitochondrial fusion and transmembrane potential in diabetic cardiovascular damage
-
批准号:10653190
-
项目类别:
-
资助金额:$10.9万
-
财政年份:2016
-
负责人:ROBERT W GILKERSON
-
依托单位:
Interaction of mitochondrial fusion and transmembrane potential in diabetic cardiovascular damage
-
批准号:10204025
-
项目类别:
-
资助金额:$10.9万
-
财政年份:2016
-
负责人:ROBERT W GILKERSON
-
依托单位:
Interaction of mitochondrial fusion and transmembrane potential in diabetic cardiovascular damage
-
批准号:10436197
-
项目类别:
-
资助金额:$10.9万
-
财政年份:2016
-
负责人:ROBERT W GILKERSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: